A.Fib Emergency Department Study Atrial Fibrillation
Patient Specific Reasons for Attending the Emergency Department in the Setting of a Background History of Atrial Fibrillation
調査の概要
状態
条件
詳細な説明
This study is a multi-centre, multi-provincial, patient survey using mixed methods. 778 patients will be enrolled from 9 centres in 3 provinces from academic, urban, and rural centres to achieve geographical and health system heterogeneity. The planned duration of the entire study (enrollment through follow-up) is approximately 12 months. Patients presenting to the ED with a primary diagnosis of AF and with a prior diagnosis of established AF will be approached to participate. Each centre will be responsible for obtaining local consent. Data will be stored confidentially and securely at the coordinating centre (Queens University, Kingston, Ontario).
Patients who meet the inclusion criteria will be invited to take part at the time of presentation to the ED or after their ED visit. For all enrolled patients, one follow up telephone call will be made within one to four weeks of the ED visit by a social scientist with specialised training in questionnaires based in Queens University, Kingston, Ontario.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Ontario
-
Kingston、Ontario、カナダ、K7L 2V7
- Kingston Health Sciences Centre - Kingston General Hospital Site
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Male or female ≥ 18 years of age
- Atrial fibrillation is the primary reason for ED visit (documented by 12-lead ECG or Holter rhythm strip by a member of the healthcare team providing care to the patient).
- Patients with an established history of AF (prior diagnosis with ECG / rhythm strip evidence of AF)
- Patient must be literate in English
- Patient must provide informed consent
Exclusion Criteria:
- Male or female < 18 years of age
- Non-English speaking
- unable and/or unwilling to consent
- Acute coronary syndrome (ischemic chest pain, ST changes, + troponin [mild troponin elevation alone does not exclude the patient])
- Cardiogenic shock or class IV congestive heart failure at the time of visit
- Enrolled in a cardiovascular drug or device research study
- New onset atrial fibrillation
研究計画
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient decisions and perceptions before an after attending the emergency department with symptoms which may be related to atrial fibrillation
時間枠：All surveys will occur within a time period of less than or equal to four weeks post emergency department visit
|
A detailed telephone survey will be performed in which patients with a known history of atrial fibrillation and symptoms which they feel are related to their diagnosis and who are agreeable to take part in the study will be called by a social scientist.
They will be asked a series of questions and their responses will be recorded either on a Likert scale (symptom severity, satisfaction with treatment, quality of life) or as qualitative data (exact symptoms, fears and concerns relating to their underlying diagnosis)
|
All surveys will occur within a time period of less than or equal to four weeks post emergency department visit
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Benedict Glover, MD、Queen's University
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。